Transglutaminase 2 limits murine peritoneal acute gout-like inflammation by regulating macrophage clearance of apoptotic neutrophils

Arthritis and Rheumatism

Volumn 54, Issue 10, 2006, Pages 3363-3371

  Rose, David M ^a,b   Sydlaske, Anya D ^a   Agha Babakhani, Amir ^a   Johnson, Kristen ^a   Terkeltaub, Robert ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; GUANOSINE DIPHOSPHATE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PURINE NUCLEOTIDE; TRANSGLUTAMINASE 2; UNCLASSIFIED DRUG; URATE;

AMIDATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BINDING SITE; CLEARANCE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; FEMALE; GOUT; INFLAMMATION; LEUKOCYTE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEUM MACROPHAGE; PERITONITIS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SYNOVITIS; TRANSAMIDATION;

EID: 33750305364     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22137     Document Type: Article

References (48)

1. Dalbeth N, Haskard DO. Inflammation and tissue damage in crystal deposition diseases. Curr Opin Rheumatol 2005;17:314-8.
2. Liu-Bryan R, Terkeltaub R. Evil humors take their toll as innate immunity makes gouty joints TREM-ble [editorial]. Arthritis Rheum 2006;54:383-6.
3. Liu-Bryan R, Scott P, Sydlaske A, Rose DM, Terkeltaub R. Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum 2005;52:2936-46.
4. Liu-Bryan R, Pritzker K, Firestein GS, Terkeltaub R. TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation. J Immunol 2005;174:5016-23.
5. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006;440:237-41.
6. Landis RC, Yagnik DR, Florey O, Philippidis P, Emons V, Mason JC, et al. Safe disposal of inflammatory monosodium urate monohydrate crystals by differentiated macrophages. Arthritis Rheum 2002;46:3026-33.
7. Terkeltaub RA, Dyer CA, Martin J, Curtiss LK. Apolipoprotein (apo) E inhibits the capacity of monosodium urate crystals to stimulate neutrophils: characterization of intraarticular apo E and demonstration of apo E binding to urate crystals in vivo. J Clin Invest 1991;87:20-6.
8. Terkeltaub R. Pathogenesis and treatment of crystal-induced inflammation. In: Koopman W, Moreland LW, editors. Arthritis and allied conditions. 15th ed. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 2357-65.
9. Yagnik DR, Evans BJ, Florey O, Mason JC, Landis RC, Haskard DO. Macrophage release of transforming growth factor β1 during resolution of monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum 2004;50:2273-80.
10. Yagnik DR, Hillyer P, Marshall D, Smythe CD, Krausz T, Haskard DO, et al. Noninflammatory phagocytosis of monosodium urate monohydrate crystals by mouse macrophages: implications for the control of joint inflammation in gout. Arthritis Rheum 2000;43:1779-89.
11. Murakami Y, Akahoshi T, Hayashi I, Endo H, Hashimoto A, Kono S, et al. Inhibition of monosodium urate monohydrate crystal-induced acute inflammation by retrovirally transfected prostaglandin D synthase. Arthritis Rheum 2003;48:2931-41.
12. Akahoshi T, Namai R, Murakami Y, Watanabe M, Matsui T, Nishimura A, et al. Rapid induction of peroxisome proliferator-activated receptor γ expression in human monocytes by monosodium urate monohydrate crystals. Arthritis Rheum 2003;48:231-9.
13. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C. Macrophage phagocytosis of aging neutrophils in inflammation: programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 1989;83:865-75.
14. Savill J, Dransfield I, Gregory C, Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2002;2:965-75.
15. Henson PM. Possible roles for apoptosis and apoptotic cell recognition in inflammation and fibrosis. Am J Respir Cell Mol Biol 2003;29 Suppl 3:S70-6.
16. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-76.
17. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J Clin Invest 1998;101:890-8.
18. Lawrence T, Willoughby DA, Gilroy DW. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 2002;2:787-95.
19. Lauber K, Blumenthal SG, Waibel M, Wesselborg S. Clearance of apoptotic cells: getting rid of the corpses. Mol Cell 2004;14:277-87.
20. Roos A, Xu W, Castellano G, Nauta A, Garred P, Daha MR, et al. Mini-review: a pivotal role for innate immunity in the clearance of apoptotic cells. Eur J Immunol 2004;34:921-9.
21. Hoffmann PR, deCathelineau AM, Ogden CA, Leverrier Y, Bratton DL, Daleke DL, et al. Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells. J Cell Biol 2001;155:649-59.
22. Szondy Z, Sarang Z, Molnar P, Nemeth T, Piacentini M, Mastroberardino PG, et al. Transglutaminase 2-1- mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells. Proc Natl Acad Sci U S A 2003;100:7812-7.
23. Falasca L, Iadevaia V, Ciccosanti F, Melino G, Serafino A, Piacentini M. Transglutaminase type II is a key element in the regulation of the anti-inflammatory response elicited by apoptotic cell engulfment. J Immunol 2005;174:7330-40.
24. Nunes I, Shapiro RL, Rifkin DB. Characterization of latent TGF-β activation by murine peritoneal macrophages. J Immunol 1995;155:1450-9.
25. Nunes I, Gleizes PE, Metz CN, Rifkin DB. Latent transforming growth factor-β binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-β. J Cell Biol 1997;136:1151-63.
26. Lorand L, Graham RM. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 2003;4:140-56.
27. Nanda N, Iismaa SE, Owens WA, Husain A, Mackay F, Graham RM. Targeted inactivation of Gh/tissue transglutaminase II. J Biol Chem 2001;276:20673-8.
28. Johnson KA, Terkeltaub RA. External GTP-bound transglutaminase 2 is a molecular switch for chondrocyte hypertrophic differentiation and calcification. J Biol Chem 2005;280:15004-12.
29. Lai CC, Boguski M, Broek D, Powers S. Influence of guanine nucleotides on complex formation between Ras and CDC25 proteins. Mol Cell Biol 1993;13:1345-52.
30. Akimov SS, Belkin AM. Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood 2001;98:1567-76.
31. Terkeltaub R, Baird S, Sears P, Santiago R, Boisvert W. The murine homolog of the interleukin-8 receptor CXCR-2 is essential for the occurrence of neutrophilic inflammation in the air pouch model of acute urate crystal-induced gouty synovitis. Arthritis Rheum 1998;41:900-9.
32. Akimov SS, Krylov D, Fleischman LF, Belkin AM. Tissue trans-glutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol 2000;148:825-38.
33. Fesus L, Piacentini M. Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci 2002;27:534-9.
34. Lai TS, Slaughter TF, Peoples KA, Hettasch JM, Greenberg CS. Regulation of human tissue transglutaminase function by magnesium-nucleotide complexes: identification of distinct binding sites for Mg-GTP and Mg-ATP. J Biol Chem 1998;273:1776-81.
35. Liu S, Cerione RA, Clardy J. Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity. Proc Natl Acad Sci U S A 2002;99:2743-7.
36. Iyoda T, Kobayashi Y. Involvement of MIP-2 and CXCR2 in neutrophil infiltration following infection of late apoptotic cells into the peritoneal cavity. Apoptosis 2004;9:485-93.
37. Cordella-Miele E, Miele L, Mukherjee AB. A novel transglutaminase- mediated post-translational modification of phospholipase A2 dramatically increases its catalytic activity. J Biol Chem 1990;265:17180-8.
38. Janiak A, Zemskov EA, Belkin AM. Cell surface transglutaminase promotes RhoA activation via integrin clustering and suppression of the Src-p190RhoGAP signaling pathway. Mol Biol Cell 2006;17:1606-19.
39. Nakaya M, Tanaka M, Okabe Y, Hanayama R, Nagata S. Opposite effects of Rho family GTPases on engulfment of apoptotic cells by macrophages. J Biol Chem 2006;281:8836-42.
40. Liote F, Prudhommeaux F, Schiltz C, Champy R, Herbelin A, Ortiz-Bravo E, et al. Inhibition and prevention of monosodium urate monohydrate crystal-induced acute inflammation in vivo by transforming growth factor β1. Arthritis Rheum 1996;39:1192-8.
41. Hwang KC, Gray CD, Sivasubramanian N, Im MJ. Interaction site of GTP binding Gh (transglutaminase II) with phospholipase C. J Biol Chem 1995;270:27058-62.
42. Kang SK, Yi KS, Kwon NS, Park KH, Kim UH, Baek KJ, et al. Alpha1B-adrenoceptor signaling and cell motility: GTPase function of Gh/transglutaminase 2 inhibits cell migration through interaction with cytoplasmic tail of integrin α subunits. J Biol Chem 2004;279:36593-600.
43. Ohta A, Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 2001;414:916-20.
44. Sitkovsky MV, Ohta A. The 'danger' sensors that STOP the immune response: the A2 adenosine receptors? Trends Immunol 2005;26:299-304.
45. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M, et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006;440:228-32.
46. Sajjadi FG, Takabayashi K, Foster AC, Domingo RC, Firestein GS. Inhibition of TNF-α expression by adenosine: role of A3 adenosine receptors. J Immunol 1996;156:3435-42.
47. Wu XW, Lee CC, Muzny DM, Caskey CT, Urate oxidase: primary structure and evolutionary implications. Proc Natl Acad Sci U S A 1989;86:9412-6.
48. Choi HK, Mount DB, Reginato AM, for the American College of Physicians and American Physiological Society. Pathogenesis of gout. Ann Intern Med 2005;143:499-516.